Speak directly with an expert in the field for insights on your cases
Review the latest updates in AML testing and treatment guidelines
Discuss whether your patients might benefit from current or future clinical trials
Ask an expert about any of the following AML-related topics:
- AML diagnostics
- FLT3 therapy
- IDH1 and IDH2 therapy
- Antibody-based therapy
- Treatment of secondary AML
- Minimal residual disease (MRD) in AML
- Transplant in AML
- BLC-2 therapy
- Fill out a short online form to request a call
- We will contact you to schedule your call within 48 hours
- Speak directly with an AML expert to get advice on diagnostics or treatment for your AML patients
Associate Professor of Medicine
Hematology Oncology Division
Feinberg School of Medicine
Associate Professor of Medicine
Cleveland Clinic Lerner College of Medicine
of Case Western Reserve University
Vice Chair, Strategy and Enterprise Development
Taussig Cancer Institute
Professor of Medicine
Director of Leukemia Program
Division of Hematologic Malignancies and Cellular Therapy
Durham, North Carolina
Director, Bone Marrow/Stem Cell Transplantation
David Geffen School of Medicine
University of California Los Angeles
Los Angeles, California
Associate Professor of Medicine
Clinical Director of Leukemia Services
Division of Hematology
University of Colorado School of Medicine
To get a one-on-one like this is like heaven. It’s really fantastic.
– Hematology/oncologist in Florida
This [format] is more one-on-one and addresses specific questions. [It’s] much more detailed and better than webinars and symposia.
– Hematology/oncologist in Arkansas
Utilizing Mutations to Individualize Therapy for Patients with Acute Myeloid Leukemia
Harry P. Erba, MD, PhD discusses the latest updates in AML diagnostics and therapies in these CME-certified videos.
This hotline is for clinicians who treat patients with AML: hematologists, medical oncologists, oncology nurses, nurse practitioners, oncology pharmacists, and other healthcare professionals.
- Describe how a comprehensive genomic assessment, including cytogenetics and molecular assessment, is necessary for optimal classification and prognosis of patients with AML
- Identify how knowledge of functional AML subsets can be used to inform selection of currently available therapeutic strategies
- Assess recent data of emerging therapeutic options for patients with AML, including advances in chemotherapies, hypomethylating agents, targeted therapies, immunotherapies, and other approaches
- Evaluate alternative strategies, including clinical trial participation, for patients with AML that are unlikely to benefit from standard chemotherapeutic approaches
This activity is jointly provided by the University of Nebraska Medical Center, Center for Continuing Education and Bio Ascend.
Copyright © Bio Ascend LLC. All Rights Reserved.
FULL TERMS AND CONDITIONS
By using this site, you signify your assent to these Terms and Conditions. If you do not agree to all of these Terms and Conditions of use, do not use this site.
The University of Nebraska Medical Center, Center for Continuing Education (“UNMC”) and Bio Ascend LLC (“Bio Ascend”) may revise and update these Terms and Conditions at any time. Your continued usage of the AML Hotline website (“Site,” or the “Site,”) will mean you accept those changes.
THE SITE DOES NOT PROVIDE MEDICAL ADVICE
Content on the Site, which may include text, graphics, images, or other information produced by UNMC and Bio Ascend or obtained from third party content providers (“Content Providers”), and other material contained on the Site, information and educational materials disseminated to you after your registration on the Site (“Content”) are for informational and educational purposes only. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a physician or other qualified expert health professional with any questions you may have regarding a medical condition.
LIABILITY OF UNMC, BIO ASCEND AND EXPERT HEALTH CARE PROFESSIONALS
The Site and Content are provided on an “AS-IS” basis. UNMC, BIO ASCEND, AND THE SITE EXPERT HEALTH CARE PROVIDERS, TO THE FULLEST EXTENT PERMITTED BY LAW, DISCLAIM ALL WARRANTIES, EITHER
EXPRESS OR IMPLIED, STATUTORY OR OTHERWISE, INCLUDING BUT NOT LIMITED TO THE IMPLIED
WARRANTIES OF MERCHANTABILITY, NON-INFRINGEMENT OF THIRD PARTIES’ RIGHTS, AND FITNESS
FOR A PARTICULAR PURPOSE.
Without limiting the foregoing, UNMC, BIO ASCEND, the Expert Health Care Professionals make no representations or warranties about the following:
- The accuracy, reliability, completeness, currentness, or timeliness of the information, software, links, or communications provided on or through the use of the Site.
- The satisfaction of any government regulations requiring disclosure of information on prescription drug products or the approval or compliance of any software tools with regard to the information contained on the Site or the information disseminated by the AML Hotline via email.
In no event shall UNMC, Bio Ascend, the Expert Health Care Professionals, or any third parties mentioned on the Site be liable for any claims or damages (including, without limitation, direct, incidental and consequential damages, personal injury/wrongful death, lost profits, or damages resulting from lost data or business interruption) resulting from the use of or inability to use the Site or the information, whether based on warranty, contract, tort, or any other legal theory, and whether or not UNMC, Bio Ascend, the Expert Health Care Professionals are advised of the possibility of such damages. UNMC, Bio Ascend, the Expert Health Care Professionals are not liable for any personal injury, including death, caused by your use or misuse of the Site, information or education materials. Any claims arising in connection with your use of the Site, information or education materials must be brought within one (1) year of the date of the event giving rise to such action occurred. Remedies under these Terms and Conditions are exclusive and are limited to those expressly provided for in these Terms and Conditions.
UNMC and Bio Ascend reserve the right to take any action it deems necessary to protect the experts, personal safety of its users, respective employees and staff, and the integrity of the respective systems and sites. UNMC and Bio Ascend have no liability or responsibility to users of the Site or any other person or entity for performance or nonperformance of the aforementioned activities.
ADVERTISEMENTS, SEARCHES AND LINKS TO OTHER SITES
UNMC and Bio Ascend may provide links to third party web sites or information. Bio Ascend does not recommend and does not endorse the content on any third-party websites. UNMC and Bio Ascend are not responsible for the content of linked third-party sites, sites framed within the Site, third-party sites provided as search results, or third-party advertisements, and do not make any representations regarding their content or accuracy. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.
INDEMNITY You agree to defend, indemnify, and hold UNMC, Bio Ascend, Expert Health Care Professionals and their respective officers, affiliates, parent company, trustees, employees, agents, Content Providers, successors and heirs, harmless from and against any claims, actions or demands, liabilities and settlements including without limitation, reasonable legal and accounting fees, resulting from, or alleged to result from, your violation of these Terms and Conditions.
Bio Ascend is a Delaware limited liability company with its principal offices in Chicago, IL, U.S.A. If you access the Site from outside the United States, you do so at your own risk and are responsible for compliance with the laws of your jurisdiction. If any provision of these Terms and Conditions is found to be invalid by any court having competent jurisdiction as described in these Terms and Conditions, the invalidity of such provision shall not affect the validity of the remaining provisions of these Terms and Conditions, which shall remain in full force and effect. No waiver of any of these Terms and Conditions shall be deemed a further or continuing waiver of such term or condition or any other term or condition. The following provisions survive the expiration or termination of these Terms and Conditions for any reason whatsoever: Liability, Indemnity, Jurisdiction, and Complete Agreement.
These Terms and Conditions are governed by the laws of the State of Illinois, without respect to its conflict of laws principles. You expressly agree that exclusive jurisdiction for any dispute with Bio Ascend, or in any way relating to your use of the Site, resides in the state and federal courts of Cook County, Illinois and you further agree and expressly consent to the exercise of personal jurisdiction in the state and federal courts of Cook County, Illinois in connection with any such dispute including any claim involving Bio Ascend or its parent company, affiliates, subsidiaries, employees, contractors, officers, directors, telecommunication providers, and content providers.
Except as expressly provided in a particular or specific notice on the Site, these Terms and Conditions and applicable UNMC and Bio Ascend Policies constitute the entire agreement between you, UNMC and Bio Ascend with respect to the use of the Site, the Content provided, and the information and educational materials.
This activity is supported by independent educational grants from AbbVie Inc., Agios Pharmaceuticals, Inc., and Daiichi Sankyo, Inc.